Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-17-000034
Filing Date
2017-10-04
Accepted
2017-10-04 17:23:28
Documents
1
Period of Report
2017-10-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3971
  Complete submission text file 0001288123-17-000034.txt   5402
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Issuer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ANTIGENICS INC. 162 FIFTH AVE., SUITE 900 NEW YORK NY 10010
Business Address
JORDAN WADIH (Reporting) CIK: 0001222090 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 171122548